nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Posaconazole—ABCB1—peripheral nervous system neoplasm	0.0206	0.544	CrCbGaD
Terconazole—Dysmenorrhoea—Topotecan—peripheral nervous system neoplasm	0.0186	0.0193	CcSEcCtD
Terconazole—Face oedema—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0122	CcSEcCtD
Terconazole—Face oedema—Isotretinoin—peripheral nervous system neoplasm	0.0117	0.0122	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.011	0.0114	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.011	0.0114	CcSEcCtD
Terconazole—Itraconazole—ABCB1—peripheral nervous system neoplasm	0.0108	0.286	CrCbGaD
Terconazole—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0107	CcSEcCtD
Terconazole—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0107	CcSEcCtD
Terconazole—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.0102	0.0106	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.00895	0.0093	CcSEcCtD
Terconazole—Face oedema—Alitretinoin—peripheral nervous system neoplasm	0.0089	0.00925	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.0083	0.00863	CcSEcCtD
Terconazole—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00784	0.00814	CcSEcCtD
Terconazole—Chills—Topotecan—peripheral nervous system neoplasm	0.00761	0.00791	CcSEcCtD
Terconazole—Face oedema—Cisplatin—peripheral nervous system neoplasm	0.00758	0.00788	CcSEcCtD
Terconazole—Chills—Isotretinoin—peripheral nervous system neoplasm	0.00755	0.00785	CcSEcCtD
Terconazole—Chills—Tretinoin—peripheral nervous system neoplasm	0.00755	0.00785	CcSEcCtD
Terconazole—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.00685	0.00712	CcSEcCtD
Terconazole—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.0068	0.00706	CcSEcCtD
Terconazole—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.0068	0.00706	CcSEcCtD
Terconazole—Malaise—Topotecan—peripheral nervous system neoplasm	0.00666	0.00692	CcSEcCtD
Terconazole—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.0066	0.00686	CcSEcCtD
Terconazole—Malaise—Tretinoin—peripheral nervous system neoplasm	0.0066	0.00686	CcSEcCtD
Terconazole—Ketoconazole—ABCB1—peripheral nervous system neoplasm	0.00648	0.171	CrCbGaD
Terconazole—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00648	0.00673	CcSEcCtD
Terconazole—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00629	0.00653	CcSEcCtD
Terconazole—Myalgia—Topotecan—peripheral nervous system neoplasm	0.00629	0.00653	CcSEcCtD
Terconazole—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00623	0.00648	CcSEcCtD
Terconazole—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.00623	0.00648	CcSEcCtD
Terconazole—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.00623	0.00648	CcSEcCtD
Terconazole—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00623	0.00648	CcSEcCtD
Terconazole—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00621	0.00645	CcSEcCtD
Terconazole—Chills—Dactinomycin—peripheral nervous system neoplasm	0.00617	0.00641	CcSEcCtD
Terconazole—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00616	0.0064	CcSEcCtD
Terconazole—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00616	0.0064	CcSEcCtD
Terconazole—Myalgia—Melphalan—peripheral nervous system neoplasm	0.00615	0.0064	CcSEcCtD
Terconazole—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00612	0.00636	CcSEcCtD
Terconazole—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00603	0.00626	CcSEcCtD
Terconazole—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00598	0.00621	CcSEcCtD
Terconazole—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00598	0.00621	CcSEcCtD
Terconazole—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0059	0.00613	CcSEcCtD
Terconazole—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00572	0.00595	CcSEcCtD
Terconazole—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00555	0.00577	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00549	0.00571	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00545	0.00566	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00545	0.00566	CcSEcCtD
Terconazole—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.0054	0.00561	CcSEcCtD
Terconazole—Influenza like illness—Epirubicin—peripheral nervous system neoplasm	0.0054	0.00561	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00538	0.00559	CcSEcCtD
Terconazole—Pain—Topotecan—peripheral nervous system neoplasm	0.00515	0.00536	CcSEcCtD
Terconazole—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00515	0.00535	CcSEcCtD
Terconazole—Pain—Tretinoin—peripheral nervous system neoplasm	0.00511	0.00531	CcSEcCtD
Terconazole—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00511	0.00531	CcSEcCtD
Terconazole—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.0051	0.0053	CcSEcCtD
Terconazole—Pain—Melphalan—peripheral nervous system neoplasm	0.00505	0.00524	CcSEcCtD
Terconazole—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00504	0.00523	CcSEcCtD
Terconazole—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00501	0.0052	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—peripheral nervous system neoplasm	0.00499	0.00519	CcSEcCtD
Terconazole—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00497	0.00516	CcSEcCtD
Terconazole—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00493	0.00512	CcSEcCtD
Terconazole—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00493	0.00512	CcSEcCtD
Terconazole—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00493	0.00512	CcSEcCtD
Terconazole—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00489	0.00508	CcSEcCtD
Terconazole—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00489	0.00508	CcSEcCtD
Terconazole—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00479	0.00497	CcSEcCtD
Terconazole—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00476	0.00495	CcSEcCtD
Terconazole—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00476	0.00495	CcSEcCtD
Terconazole—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00475	0.00494	CcSEcCtD
Terconazole—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00475	0.00494	CcSEcCtD
Terconazole—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00473	0.00491	CcSEcCtD
Terconazole—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00473	0.00491	CcSEcCtD
Terconazole—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00472	0.00491	CcSEcCtD
Terconazole—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00472	0.00491	CcSEcCtD
Terconazole—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00472	0.00491	CcSEcCtD
Terconazole—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00472	0.00491	CcSEcCtD
Terconazole—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00469	0.00487	CcSEcCtD
Terconazole—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00467	0.00485	CcSEcCtD
Terconazole—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00455	0.00473	CcSEcCtD
Terconazole—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00453	0.00471	CcSEcCtD
Terconazole—Chills—Etoposide—peripheral nervous system neoplasm	0.00447	0.00464	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00445	0.00463	CcSEcCtD
Terconazole—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00444	0.00461	CcSEcCtD
Terconazole—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0044	0.00458	CcSEcCtD
Terconazole—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0044	0.00458	CcSEcCtD
Terconazole—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00439	0.00456	CcSEcCtD
Terconazole—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00436	0.00454	CcSEcCtD
Terconazole—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00435	0.00452	CcSEcCtD
Terconazole—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00432	0.00449	CcSEcCtD
Terconazole—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00429	0.00446	CcSEcCtD
Terconazole—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00429	0.00446	CcSEcCtD
Terconazole—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00426	0.00443	CcSEcCtD
Terconazole—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00426	0.00443	CcSEcCtD
Terconazole—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00423	0.0044	CcSEcCtD
Terconazole—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00423	0.0044	CcSEcCtD
Terconazole—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00423	0.0044	CcSEcCtD
Terconazole—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00418	0.00434	CcSEcCtD
Terconazole—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00417	0.00434	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00413	0.00429	CcSEcCtD
Terconazole—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00403	0.00418	CcSEcCtD
Terconazole—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00403	0.00418	CcSEcCtD
Terconazole—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00402	0.00418	CcSEcCtD
Terconazole—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00399	0.00415	CcSEcCtD
Terconazole—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00398	0.00414	CcSEcCtD
Terconazole—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00398	0.00413	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00398	0.00413	CcSEcCtD
Terconazole—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00395	0.00411	CcSEcCtD
Terconazole—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00395	0.00411	CcSEcCtD
Terconazole—Malaise—Etoposide—peripheral nervous system neoplasm	0.00391	0.00406	CcSEcCtD
Terconazole—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00389	0.00405	CcSEcCtD
Terconazole—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00387	0.00403	CcSEcCtD
Terconazole—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00386	0.00401	CcSEcCtD
Terconazole—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00386	0.00401	CcSEcCtD
Terconazole—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00386	0.00401	CcSEcCtD
Terconazole—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00383	0.00398	CcSEcCtD
Terconazole—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0038	0.00395	CcSEcCtD
Terconazole—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0038	0.00395	CcSEcCtD
Terconazole—Rash—Topotecan—peripheral nervous system neoplasm	0.0038	0.00395	CcSEcCtD
Terconazole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0038	0.00394	CcSEcCtD
Terconazole—Headache—Topotecan—peripheral nervous system neoplasm	0.00377	0.00392	CcSEcCtD
Terconazole—Rash—Tretinoin—peripheral nervous system neoplasm	0.00377	0.00392	CcSEcCtD
Terconazole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00377	0.00392	CcSEcCtD
Terconazole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00377	0.00391	CcSEcCtD
Terconazole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00377	0.00391	CcSEcCtD
Terconazole—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00375	0.0039	CcSEcCtD
Terconazole—Headache—Tretinoin—peripheral nervous system neoplasm	0.00374	0.00389	CcSEcCtD
Terconazole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00374	0.00389	CcSEcCtD
Terconazole—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00373	0.00388	CcSEcCtD
Terconazole—Pain—Vincristine—peripheral nervous system neoplasm	0.00373	0.00388	CcSEcCtD
Terconazole—Rash—Melphalan—peripheral nervous system neoplasm	0.00372	0.00387	CcSEcCtD
Terconazole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00372	0.00386	CcSEcCtD
Terconazole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.0037	0.00385	CcSEcCtD
Terconazole—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00364	0.00379	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00363	0.00377	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.0036	0.00374	CcSEcCtD
Terconazole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0036	0.00374	CcSEcCtD
Terconazole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0036	0.00374	CcSEcCtD
Terconazole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00358	0.00372	CcSEcCtD
Terconazole—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00358	0.00372	CcSEcCtD
Terconazole—Nausea—Topotecan—peripheral nervous system neoplasm	0.00358	0.00372	CcSEcCtD
Terconazole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00357	0.00371	CcSEcCtD
Terconazole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00355	0.00369	CcSEcCtD
Terconazole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00355	0.00369	CcSEcCtD
Terconazole—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00354	0.00368	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00352	0.00365	CcSEcCtD
Terconazole—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00351	0.00364	CcSEcCtD
Terconazole—Nausea—Melphalan—peripheral nervous system neoplasm	0.0035	0.00364	CcSEcCtD
Terconazole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00345	0.00359	CcSEcCtD
Terconazole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00345	0.00359	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00336	0.00349	CcSEcCtD
Terconazole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00334	0.00347	CcSEcCtD
Terconazole—Pain—Cisplatin—peripheral nervous system neoplasm	0.0033	0.00343	CcSEcCtD
Terconazole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00325	0.00338	CcSEcCtD
Terconazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00322	0.00334	CcSEcCtD
Terconazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0032	0.00333	CcSEcCtD
Terconazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00318	0.00331	CcSEcCtD
Terconazole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00313	0.00325	CcSEcCtD
Terconazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00311	0.00323	CcSEcCtD
Terconazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00308	0.0032	CcSEcCtD
Terconazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00305	0.00317	CcSEcCtD
Terconazole—Pain—Etoposide—peripheral nervous system neoplasm	0.00302	0.00314	CcSEcCtD
Terconazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.003	0.00311	CcSEcCtD
Terconazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00291	0.00303	CcSEcCtD
Terconazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0029	0.00302	CcSEcCtD
Terconazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00289	0.00301	CcSEcCtD
Terconazole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00289	0.003	CcSEcCtD
Terconazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00299	CcSEcCtD
Terconazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.00297	CcSEcCtD
Terconazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00297	CcSEcCtD
Terconazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00284	0.00296	CcSEcCtD
Terconazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00284	0.00295	CcSEcCtD
Terconazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00281	0.00292	CcSEcCtD
Terconazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0028	0.00291	CcSEcCtD
Terconazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.0028	0.00291	CcSEcCtD
Terconazole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00278	0.00288	CcSEcCtD
Terconazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00277	0.00288	CcSEcCtD
Terconazole—Rash—Vincristine—peripheral nervous system neoplasm	0.00275	0.00286	CcSEcCtD
Terconazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00275	0.00286	CcSEcCtD
Terconazole—Headache—Vincristine—peripheral nervous system neoplasm	0.00273	0.00284	CcSEcCtD
Terconazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00269	0.0028	CcSEcCtD
Terconazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00261	0.00271	CcSEcCtD
Terconazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.00259	0.00269	CcSEcCtD
Terconazole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00254	0.00264	CcSEcCtD
Terconazole—Chills—Epirubicin—peripheral nervous system neoplasm	0.0025	0.0026	CcSEcCtD
Terconazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.0025	0.0026	CcSEcCtD
Terconazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00245	0.00255	CcSEcCtD
Terconazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.00243	0.00253	CcSEcCtD
Terconazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00243	0.00253	CcSEcCtD
Terconazole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00234	0.00243	CcSEcCtD
Terconazole—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.00241	CcSEcCtD
Terconazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00229	0.00238	CcSEcCtD
Terconazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00225	0.00234	CcSEcCtD
Terconazole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00225	0.00234	CcSEcCtD
Terconazole—Rash—Etoposide—peripheral nervous system neoplasm	0.00223	0.00232	CcSEcCtD
Terconazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00223	0.00232	CcSEcCtD
Terconazole—Headache—Etoposide—peripheral nervous system neoplasm	0.00222	0.0023	CcSEcCtD
Terconazole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00219	0.00228	CcSEcCtD
Terconazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.0021	0.00218	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00217	CcSEcCtD
Terconazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00215	CcSEcCtD
Terconazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00215	CcSEcCtD
Terconazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00204	0.00212	CcSEcCtD
Terconazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00211	CcSEcCtD
Terconazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00206	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00199	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00199	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00189	0.00196	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00191	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00188	CcSEcCtD
Terconazole—Pain—Epirubicin—peripheral nervous system neoplasm	0.00169	0.00176	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00174	CcSEcCtD
Terconazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00163	0.0017	CcSEcCtD
Terconazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00168	CcSEcCtD
Terconazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00164	CcSEcCtD
Terconazole—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00163	CcSEcCtD
Terconazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00163	CcSEcCtD
Terconazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00163	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00157	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00156	CcSEcCtD
Terconazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00152	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00151	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00151	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00151	CcSEcCtD
Terconazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00148	CcSEcCtD
Terconazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.0014	0.00146	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.0014	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00137	CcSEcCtD
Terconazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00136	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.00135	CcSEcCtD
Terconazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00131	CcSEcCtD
Terconazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.00125	0.0013	CcSEcCtD
Terconazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00125	0.0013	CcSEcCtD
Terconazole—Headache—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00129	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00126	CcSEcCtD
Terconazole—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00122	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00121	CcSEcCtD
Terconazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.0012	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.0012	CcSEcCtD
Terconazole—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Terconazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00113	CcSEcCtD
